Search
News Archive
Categories
Scots and Nordic scientists set to explore sustainable skincare utilizing marine natural ingredients
Posted On: January 30, 2012Scottish company Aquapharm has joined forces with Norwegian firm Aqua Bio Technology (ABT) to create a new generation of sustainable ingredients for the skincare market.
Together the companies hope to identify natural marine ingredients that could replace the petroleum-based components used extensively within the skincare market.
Scientists at Aquapharm believe marine microbes are the key to finding the bio-active ingredients of the future, and have developed specialist fermentation processes to source and produce such extracts.
Now they will undertake a development program in conjunction with ABT, sharing their expertise in a bid to prove these extracts can be produced with minimal environmental impact – and successfully commercialized for the personal care market.
Mar. Drugs, Volume 9, Issue 12 (December 2011), Pages 2488-2817 Release issue
Posted On: December 27, 2011MDPI is pleased to announce the publication of the following issue:Mar. Drugs, Volume 9, Issue 12 (December 2011), Pages 2488-2817 at http://www.mdpi.com/1660-3397/9/12/
Table of Contents:
Jeen-Kuan Chen, Chao-Hsien Yeh, Lian-Chen Wang, Tzong-Horng Liou, Chia-Rui Shen and Chao-Lin Liu
Article: Chitosan, the Marine Functional Food, Is a Potent Adsorbent of Humic Acid
Mar. Drugs 2011, 9(12), 2488-2498; doi:10.3390/md9122488
http://www.mdpi.com/1660-3397/9/12/2488/
Oriol Sacristan-Soriano, Bernard Banaigs and Mikel A. Becerro
Article: Relevant Spatial Scales of Chemical Variation in Aplysina aerophoba
Mar. Drugs 2011, 9(12), 2499-2513; doi:10.3390/md9122499
http://www.mdpi.com/1660-3397/9/12/2499/
Jeannette Vera, Jorge Castro, Alberto Gonzalez and Alejandra Moenne
Review: Seaweed Polysaccharides and Derived Oligosaccharides Stimulate Defense Responses and Protection Against Pathogens in Plants
Mar. Drugs 2011, 9(12), 2514-2525; doi:10.3390/md9122514
http://www.mdpi.com/1660-3397/9/12/2514/
Nai-Lun Lee and Jui-Hsin Su
Article: Tetrahydrofuran Cembranoids from the Cultured Soft Coral Lobophytum crassum
Mar. Drugs 2011, 9(12), 2526-2536; doi:10.3390/md9122526
http://www.mdpi.com/1660-3397/9/12/2526/
Maria Mansson, Anita Nielsen, Louise Kjærulff, Charlotte H. Gotfredsen, Matthias Wietz, Hanne Ingmer, Lone Gram and Thomas O. Larsen
Article: Inhibition of Virulence Gene Expression in Staphylococcus aureus by Novel Depsipeptides from a Marine Photobacterium
Mar. Drugs 2011, 9(12), 2537-2552; doi:10.3390/md9122537
http://www.mdpi.com/1660-3397/9/12/2537/
Julianne Dyble, Duane Gossiaux, Peter Landrum, Donna R. Kashian and Steven Pothoven
Article: A Kinetic Study of Accumulation and Elimination of Microcystin-LR in Yellow Perch (Perca Flavescens) Tissue and Implications for Human Fish Consumption
Mar. Drugs 2011, 9(12), 2553-2571; doi:10.3390/md9122553
http://www.mdpi.com/1660-3397/9/12/2553/
Massimiliano Borgogna, Barbara Bellich and Attilio Cesàro
Review: Marine Polysaccharides in Microencapsulation and Application to Aquaculture: “From Sea to Sea”
Mar. Drugs 2011, 9(12), 2572-2604; doi:10.3390/md9122572
http://www.mdpi.com/1660-3397/9/12/2572/
Marcel Tutor Ale, Hiroko Maruyama, Hidekazu Tamauchi, Jørn D. Mikkelsen and Anne S. Meyer
Article: Fucose-Containing Sulfated Polysaccharides from Brown Seaweeds Inhibit Proliferation of Melanoma Cells and Induce Apoptosis by Activation of Caspase-3 in Vitro
Mar. Drugs 2011, 9(12), 2605-2621; doi:10.3390/md9122605
http://www.mdpi.com/1660-3397/9/12/2605/
Ching-Chyuan Su, Jui-Hsin Su, Jen-Jie Lin, Cheng-Chi Chen, Wen-Ing Hwang, Han Hsiang Huang and Yu-Jen Wu
Article: An Investigation into the Cytotoxic Effects of 13-Acetoxysarcocrassolide from the Soft Coral Sarcophyton crassocaule on Bladder Cancer Cells
Mar. Drugs 2011, 9(12), 2622-2642; doi:10.3390/md9122622
http://www.mdpi.com/1660-3397/9/12/2622/
Priscilla L. Winder, Shirley A. Pomponi and Amy E. Wright
Review: Natural Products from the Lithistida: A Review of the Literature since 2000
Mar. Drugs 2011, 9(12), 2643-2682; doi:10.3390/md9122643
http://www.mdpi.com/1660-3397/9/12/2643/
Asuncion Rocher, Ana Isabel Caceres, Ana Obeso and Constancio Gonzalez
Review: Tetrodotoxin as a Tool to Elucidate Sensory Transduction Mechanisms: The Case for the Arterial Chemoreceptors of the Carotid Body
Mar. Drugs 2011, 9(12), 2683-2704; doi:10.3390/md9122683
http://www.mdpi.com/1660-3397/9/12/2683/
Shih-Tseng Lin, Shang-Kwei Wang and Chang-Yih Duh
Article: Cembranoids from the Dongsha Atoll Soft Coral Lobophytum crassum
Mar. Drugs 2011, 9(12), 2705-2716; doi:10.3390/md9122705
http://www.mdpi.com/1660-3397/9/12/2705/
Charles B. Berde, Umeshkumar Athiraman, Barak Yahalom, David Zurakowski, Gabriel Corfas and Christina Bognet
Article: Tetrodotoxin-Bupivacaine-Epinephrine Combinations for Prolonged Local Anesthesia
Mar. Drugs 2011, 9(12), 2717-2728; doi:10.3390/md9122717
http://www.mdpi.com/1660-3397/9/12/2717/
Aloysio da S. Ferrão-Filho and Betina Kozlowsky-Suzuki
Review: Cyanotoxins: Bioaccumulation and Effects on Aquatic Animals
Mar. Drugs 2011, 9(12), 2729-2772; doi:10.3390/md9122729
http://www.mdpi.com/1660-3397/9/12/2729/
Yang-Chang Wu, Jui-Hsin Su, Tai-Ting Chou, Yin-Pin Cheng, Ching-Feng Weng, Chia-Hung Lee, Lee-Shing Fang, Wei-Hsien Wang, Jan-Jung Li, Mei-Chin Lu, Jimmy Kuo, Jyh-Horng Sheu and Ping-Jyun Sung
Review: Natural Product Chemistry of Gorgonian Corals of Genus Junceella—Part II
Mar. Drugs 2011, 9(12), 2773-2792; doi:10.3390/md9122773
http://www.mdpi.com/1660-3397/9/12/2773/
Kumiko Yokogawa, Isao Matsui-Yuasa, Akiko Tamura, Masaki Terada and Akiko Kojima-Yuasa
Article: Inhibitory Effects of Ecklonia cava Extract on High Glucose-Induced Hepatic Stellate Cell Activation
Mar. Drugs 2011, 9(12), 2793-2808; doi:10.3390/md9122793
http://www.mdpi.com/1660-3397/9/12/2793/
Rihab F. Angawi, Giorgio Bavestrello, Barbara Calcinai, Henny Adeleida Dien, Giovanna Donnarumma, Maria Antonietta Tufano, Iole Paoletti, Elena Grimaldi, Giuseppina Chianese, Ernesto Fattorusso and Orazio Taglialatela-Scafati
Article: Aurantoside J: a New Tetramic Acid Glycoside from Theonella swinhoei. Insights into the Antifungal Potential of Aurantosides
Mar. Drugs 2011, 9(12), 2809-2817; doi:10.3390/md9122809
http://www.mdpi.com/1660-3397/9/12/2809/
Aquapharm and CABI sign collaborative agreement
Posted On: October 6, 2011Scottish marine biotechnology firm Aquapharm has signed an agreement with the Centre for Agricultural Bioscience International (CABI) which will allow the organisations to access and co-promote one another’s unique microbe collections.
Aquapharm specialises in the discovery, isolation and development of novel functional active ingredients, sustainably harvested from marine micro-organisms for potential use in a wide range of commercial sectors.
Meanwhile not-for-profit organisation CABI – which is highly respected for its cutting-edge research – applies scientific expertise to solve problems in agriculture and the environment, with a focus on scientific publishing, development and research, and microbial services.
The agreement sets out how Aquapharm and CABI will share know-how and resources, paving the way for the future commercialisation of a variety of microbial strains/extracts.
Aquapharm Biodiscovery renews deal with Croda/Sederma, harnessing Aquapharm’s collection of marine micro-organisms for cosmetics
Posted On: July 12, 2011Leading Scottish marine biotechnology company, Aquapharm Biodiscovery Ltd, has reached a crucial new stage in the development of next generation cosmetics harnessing its unique collection of marine micro-organisms.
Aquapharm, which signed a three year R&D agreement with Croda, a global leader in speciality chemicals for the personal care market in 2008, has struck a renewed deal to work with Croda’s highly respected cosmetics subsidiary, Sederma, to advance a shortlist of naturally sourced candidates identified during the collaboration towards the market.
Prof. Simon Best, CEO of Aquapharm, explains: “I’m delighted that Sederma and Aquapharm will continue to build on the foundations established through our successful collaboration with Croda; it confirms the rich potential of our marine microbe collection as a source of next generation cosmetic ingredients for skincare application. We are now on course to see the first of our products launched to market as early as 2013.”
Dr Keith Layden, President, Croda Enterprise Technology, says: “Aquapharm is one of the UK’s most promising biotech firms, breaking new ground with its pioneering research into marine natural products. Our collaboration thus far has led to many exciting new developments which promise to deliver novel and sustainable solutions for the personal care industry.
AE Biofuels acquires biotechnology company Zymetis and patented marine organism Z-microbe
Posted On: July 7, 2011AE Biofuels, Inc. has completed the acquisition of Zymetis, Inc., a Maryland-based industrial biotechnology company that develops products for the renewable chemicals and advanced fuels industries. Zymetis, Inc. will continue as a wholly-owned subsidiary of AE Biofuels.